Equivalence Study to Compare Two Strengths of Creon in China
NCT03450772
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Pancreatic Insufficiency
Interventions
DRUG:
Creon® 25000
DRUG:
Creon® 10000
Sponsor
Abbott